{"hands_on_practices": [{"introduction": "This practice delves into the concept of the adenylate energy charge (AEC), a cornerstone of metabolic regulation. The AEC provides a quantitative measure of a cell's energetic state by consolidating the concentrations of ATP, ADP, and AMP into a single, powerful index. In this exercise ([@problem_id:2774205]), you will calculate the AEC from given concentrations and use this value to predict the regulatory response of key enzymes in glycolysis and gluconeogenesis, providing a tangible link between cellular energy balance and metabolic pathway control.", "problem": "A cytosolic extract from a mammalian hepatocyte at steady state has measured adenylate pools of adenosine triphosphate (ATP), adenosine diphosphate (ADP), and adenosine monophosphate (AMP) equal to $[ATP] = 3 \\text{ mM}$, $[ADP] = 0.5 \\text{ mM}$, and $[AMP] = 0.1 \\text{ mM}$. Starting from the canonical definition of the adenylate energy charge (AEC), which quantifies the fraction of phosphoryl transfer potential within the adenylate pool and is constrained between $0$ and $1$, compute the energy charge for this sample.\n\nPhosphofructokinase-1 (PFK-1) and fructose-1,6-bisphosphatase-1 (FBPase-1) are oppositely regulated by AMP: AMP allosterically activates PFK-1 and allosterically inhibits FBPase-1. To translate the qualitative prediction into a calculation, define the AMP fraction of the adenylate pool as $f_{\\mathrm{AMP}} \\equiv \\dfrac{[AMP]}{[ATP]+[ADP]+[AMP]}$, and define a sign function $s \\equiv \\operatorname{sgn}\\!\\big(f_{\\mathrm{AMP}}-0.05\\big)$, where $\\operatorname{sgn}(x)=-1$ if $x0$, $\\operatorname{sgn}(x)=0$ if $x=0$, and $\\operatorname{sgn}(x)=1$ if $x0$. Encode the AMP-mediated activity change of PFK-1 as $c_{\\mathrm{PFK}} \\equiv s$ and that of FBPase-1 as $c_{\\mathrm{FBP}} \\equiv -s$.\n\nProvide your final result as a row matrix $\\big(E_c,\\;c_{\\mathrm{PFK}},\\;c_{\\mathrm{FBP}}\\big)$, where $E_c$ is the adenylate energy charge. Round $E_c$ to four significant figures. Do not include units in the final answer.", "solution": "The adenylate energy charge (AEC) formalism quantifies the usable phosphoryl transfer potential contained in the adenylate pool. The fundamental basis is that adenosine triphosphate (ATP) contains two phosphoanhydride bonds available for phosphoryl transfer, adenosine diphosphate (ADP) contains one, and adenosine monophosphate (AMP) contains none. Let the total number of phosphoanhydride bonds per unit volume be counted as\n$$\nB_{\\mathrm{tot}} = 2[ATP] + 1[ADP] + 0[AMP].\n$$\nLet the total adenylate pool concentration be\n$$\nA_{\\mathrm{tot}} = [ATP]+[ADP]+[AMP].\n$$\nThe average number of phosphoanhydride bonds per adenylate molecule is then $B_{\\mathrm{tot}}/A_{\\mathrm{tot}}$, and the theoretical maximum is $2$. Hence the adenylate energy charge $E_c$ is the normalized average,\n$$\nE_c = \\frac{B_{\\mathrm{tot}}}{2A_{\\mathrm{tot}}} = \\frac{2[ATP]+[ADP]}{2\\big([ATP]+[ADP]+[AMP]\\big)} = \\frac{[ATP]+\\tfrac{1}{2}[ADP]}{[ATP]+[ADP]+[AMP]}.\n$$\nThis definition is a well-tested and widely used descriptor introduced by Atkinson to capture the control of metabolism by the adenylate system.\n\nInsert the measured concentrations $[ATP]=3 \\text{ mM}$, $[ADP]=0.5 \\text{ mM}$, $[AMP]=0.1 \\text{ mM}$. First compute the total adenylate pool:\n$$\nA_{\\mathrm{tot}} = 3 + 0.5 + 0.1 = 3.6 \\ \\text{mM}.\n$$\nCompute the numerator of the energy charge:\n$$\n[ATP]+\\tfrac{1}{2}[ADP] = 3 + \\tfrac{1}{2}\\times 0.5 = 3 + 0.25 = 3.25 \\ \\text{mM}.\n$$\nTherefore,\n$$\nE_c = \\frac{3.25}{3.6} = \\frac{325}{360} = \\frac{65}{72} \\approx 0.902777\\ldots\n$$\nRounded to four significant figures, $E_c = 0.9028$.\n\nNext, compute the AMP fraction of the adenylate pool:\n$$\nf_{\\mathrm{AMP}} = \\frac{[AMP]}{A_{\\mathrm{tot}}} = \\frac{0.1}{3.6} = \\frac{1}{36} \\approx 0.027777\\ldots\n$$\nEvaluate the sign function relative to the threshold $0.05$:\n$$\ns = \\operatorname{sgn}\\!\\big(f_{\\mathrm{AMP}} - 0.05\\big) = \\operatorname{sgn}\\!\\big(0.027777\\ldots - 0.05\\big) = \\operatorname{sgn}(-0.022222\\ldots) = -1.\n$$\nBy definition of the encoding,\n$$\nc_{\\mathrm{PFK}} = s = -1, \\qquad c_{\\mathrm{FBP}} = -s = 1.\n$$\nThis reflects the opposite allosteric regulation by AMP: with a low AMP fraction (below the specified threshold), the AMP-mediated activation of phosphofructokinase-1 (PFK-1) is reduced (encoded $-1$), whereas the AMP-mediated inhibition of fructose-1,6-bisphosphatase-1 (FBPase-1) is relieved (encoded $1$).\n\nCollecting the results and formatting as requested yields the row matrix $\\big(E_c,\\;c_{\\mathrm{PFK}},\\;c_{\\mathrm{FBP}}\\big)$ with $E_c$ rounded to four significant figures.", "answer": "$$\\boxed{\\begin{pmatrix}0.9028  -1  1\\end{pmatrix}}$$", "id": "2774205"}, {"introduction": "Building on the idea of metabolic sensing, this exercise explores the dynamic consequences of allosteric regulation. We will use the Hill equation, a powerful phenomenological model, to analyze the behavior of phosphofructokinase-1 (PFK-1), a critical control point in glycolysis. This practice ([@problem_id:2774210]) demonstrates how the cooperative binding of a substrate, modulated by an allosteric activator, can lead to a highly sensitive, or 'ultrasensitive,' response, where a small change in a regulatory signal produces a dramatically amplified change in metabolic flux.", "problem": "A eukaryotic cell maintains glycolytic flux through phosphofructokinase-1 (PFK-1), which is allosterically activated by fructose-2,6-bisphosphate (F2,6BP). Assume that PFK-1 displays positive cooperativity with Hill coefficient $n_H=3$ for its substrate fructose-6-phosphate (F6P), and that the allosteric activator F2,6BP reduces the apparent half-saturation constant $K_{0.5}$ for F6P without altering the catalytic maximum $V_{\\max}$. Under a sustained hormonal stimulus, the intracellular F2,6BP concentration increases by a factor of $2$, and this modulation halves the apparent $K_{0.5}$ for F6P, while leaving $n_H$ and $V_{\\max}$ unchanged. The cellular metabolic state is such that other enzymes in the pathway have negligible flux control, so that the steady-state glycolytic flux equals the PFK-1 rate. The pre-stimulus F6P concentration equals the pre-stimulus $K_{0.5}$ and remains effectively constant during the short time window in which the F2,6BP elevation occurs.\n\nStarting from foundational principles of enzyme cooperativity and steady-state metabolic control, determine the fold-change in steady-state glycolytic flux caused solely by the halving of $K_{0.5}$ under these conditions. Report the answer as a single dimensionless number, rounded to $4$ significant figures.", "solution": "The enzymatic rate $v$ for an allosteric enzyme exhibiting cooperativity can be described by the Hill equation:\n$$\nv = V_{\\max} \\frac{[S]^{n_H}}{K_{0.5}^{n_H} + [S]^{n_H}}\n$$\nwhere $v$ is the reaction velocity, $V_{\\max}$ is the maximum velocity, $[S]$ is the substrate concentration, $n_H$ is the Hill coefficient, and $K_{0.5}$ is the substrate concentration at which the velocity is half of $V_{\\max}$.\n\nWe are given the following parameters and conditions:\nThe substrate is fructose-6-phosphate, which we will denote as $S$.\nThe Hill coefficient is $n_H = 3$.\nThe maximum velocity $V_{\\max}$ and the Hill coefficient $n_H$ are constant throughout the process.\n\nLet us define the pre-stimulus (initial) state with the subscript $1$.\nThe initial PFK-1 rate is $v_1$.\nThe initial substrate concentration is $[S]_1$.\nThe initial half-saturation constant is $K_{0.5, 1}$.\nThe problem states that the pre-stimulus substrate concentration is equal to the pre-stimulus half-saturation constant:\n$$\n[S]_1 = K_{0.5, 1}\n$$\nWe can now calculate the initial flux $v_1$, which equals the PFK-1 rate, by substituting these conditions into the Hill equation:\n$$\nv_1 = V_{\\max} \\frac{[S]_1^{n_H}}{K_{0.5, 1}^{n_H} + [S]_1^{n_H}} = V_{\\max} \\frac{K_{0.5, 1}^3}{K_{0.5, 1}^3 + K_{0.5, 1}^3} = V_{\\max} \\frac{K_{0.5, 1}^3}{2 K_{0.5, 1}^3} = \\frac{1}{2} V_{\\max}\n$$\n\nNext, we define the post-stimulus (final) state with the subscript $2$.\nThe final PFK-1 rate is $v_2$.\nThe final substrate concentration is $[S]_2$.\nThe final half-saturation constant is $K_{0.5, 2}$.\nAccording to the problem, the substrate concentration remains effectively constant:\n$$\n[S]_2 = [S]_1 = K_{0.5, 1}\n$$\nThe allosteric activation by F2,6BP halves the apparent half-saturation constant:\n$$\nK_{0.5, 2} = \\frac{1}{2} K_{0.5, 1}\n$$\nWe can now calculate the final flux $v_2$ by substituting these new conditions into the Hill equation, recalling that $V_{\\max}$ and $n_H$ are unchanged:\n$$\nv_2 = V_{\\max} \\frac{[S]_2^{n_H}}{K_{0.5, 2}^{n_H} + [S]_2^{n_H}} = V_{\\max} \\frac{(K_{0.5, 1})^3}{\\left(\\frac{1}{2} K_{0.5, 1}\\right)^3 + (K_{0.5, 1})^3}\n$$\nSimplifying the expression:\n$$\nv_2 = V_{\\max} \\frac{K_{0.5, 1}^3}{\\frac{1}{8} K_{0.5, 1}^3 + K_{0.5, 1}^3} = V_{\\max} \\frac{K_{0.5, 1}^3}{K_{0.5, 1}^3 \\left(\\frac{1}{8} + 1\\right)} = V_{\\max} \\frac{1}{\\frac{9}{8}} = \\frac{8}{9} V_{\\max}\n$$\n\nThe problem asks for the fold-change in the steady-state glycolytic flux, which is the ratio of the final flux $v_2$ to the initial flux $v_1$.\n$$\n\\text{Fold-change} = \\frac{v_2}{v_1} = \\frac{\\frac{8}{9} V_{\\max}}{\\frac{1}{2} V_{\\max}}\n$$\nThe $V_{\\max}$ terms cancel, yielding:\n$$\n\\text{Fold-change} = \\frac{8}{9} \\times 2 = \\frac{16}{9}\n$$\nTo provide the answer as a single dimensionless number rounded to $4$ significant figures, we perform the division:\n$$\n\\frac{16}{9} \\approx 1.7777...\n$$\nRounding this value to $4$ significant figures gives $1.778$. This result quantifies the amplification of the metabolic signal due to the sigmoidal kinetics of the allosterically regulated enzyme. A halving of the apparent $K_{0.5}$ results in a greater-than-proportional increase in flux.", "answer": "$$\n\\boxed{1.778}\n$$", "id": "2774210"}, {"introduction": "This final practice advances our analysis of metabolic control by examining the principles of cooperative feedback inhibition and system sensitivity. You will derive the flux response to an end-product inhibitor and calculate a formal response coefficient, which quantifies the system's ultrasensitivity. This problem ([@problem_id:2774288]) challenges you to connect the molecular property of cooperativity, represented by the Hill coefficient $n$, directly to the macroscopic behavior of a metabolic pathway, illustrating how cells achieve precise and robust control over their biochemical networks.", "problem": "A single-branch metabolic pathway has a committed first step catalyzed by enzyme $E$, which is subject to rapid allosteric feedback inhibition by the pathway end-product $P$. Assume that substrate for $E$ is saturating so that the catalytic step is rate-limiting and the pathway flux $J$ is proportional to the fraction of enzyme molecules in the catalytically active conformation. Let the total enzyme concentration be $E_T$ and the catalytic turnover rate when active be $k_{\\mathrm{cat}}$, so that in the absence of inhibitor the flux is $J_0 = k_{\\mathrm{cat}} E_T$. The inhibitor $P$ binds to an allosteric regulatory site in a strongly cooperative, concerted manner (consistent with the phenomenological Hill limit of the Monod-Wyman-Changeux model) such that either zero or $n$ inhibitor molecules are bound at once, with an apparent dissociation constant $K_I$ at the active-to-inactive transition. Binding of $P$ renders the enzyme inactive.\n\nUsing only mass-action equilibrium for ligand binding, the quasi-steady-state approximation for rapid binding relative to catalysis, and the definition that ultrasensitivity is captured by the local log-log response $R(P) \\equiv \\left|\\frac{d \\ln J}{d \\ln P}\\right|$, do the following:\n\n- Derive the functional dependence $J(P)$ of the flux on the inhibitor concentration $P$ under the above assumptions, and then obtain an explicit expression for $R(P)$.\n- Evaluate $R(P)$ at $P = K_I$ and interpret how positive cooperativity (larger $n$) generates ultrasensitive control of flux around $P \\approx K_I$.\n\nFinally, suppose the pathway operates at a baseline end-product concentration $P_0 = K_I$, and a perturbation instantaneously doubles the inhibitor concentration to $2 P_0$. Determine the Hill coefficient $n$ required so that the steady-state flux decreases by exactly a factor of $5$ from its baseline value following this twofold increase in $P$. Provide your final answer as a closed-form analytical expression for $n$ with no numerical approximation.", "solution": "The model describes a two-state system for the enzyme $E$: an active state, $E_A$, and an inactive state, $E_I$. The total enzyme concentration, $E_T$, is conserved:\n$$ E_T = [E_A] + [E_I] $$\nThe transition to the inactive state is caused by the concerted binding of $n$ molecules of the inhibitor $P$:\n$$ E_A + nP \\rightleftharpoons E_I $$\nUnder the assumption of rapid binding equilibrium, we can write the mass-action expression for this process. The problem defines $K_I$ as the apparent dissociation constant. In the context of the Hill model, this implies a relationship of the form:\n$$ [E_I] = [E_A] \\frac{[P]^n}{K_I^n} $$\nThis formulation is consistent with defining $K_I$ as the concentration of $P$ at which $[E_A] = [E_I]$ (i.e., half-inhibition). Substituting this into the conservation equation for the enzyme:\n$$ E_T = [E_A] + [E_A] \\frac{[P]^n}{K_I^n} = [E_A] \\left( 1 + \\left(\\frac{[P]}{K_I}\\right)^n \\right) $$\nThe fraction of enzyme in the active state, $f_A$, is $\\frac{[E_A]}{E_T}$:\n$$ f_A = \\frac{[E_A]}{[E_A] \\left( 1 + \\left(\\frac{[P]}{K_I}\\right)^n \\right)} = \\frac{1}{1 + \\left(\\frac{P}{K_I}\\right)^n} $$\nwhere we now use $P$ to denote its concentration $[P]$. The flux $J$ is proportional to the concentration of active enzyme: $J = k_{\\mathrm{cat}} [E_A]$. Since $J_0 = k_{\\mathrm{cat}} E_T$, we can write the flux as:\n$$ J(P) = k_{\\mathrm{cat}} ([E_A]) = k_{\\mathrm{cat}} (f_A \\cdot E_T) = f_A \\cdot (k_{\\mathrm{cat}} E_T) = J_0 \\cdot f_A $$\nTherefore, the functional dependence $J(P)$ is derived:\n$$ J(P) = J_0 \\frac{1}{1 + \\left(\\frac{P}{K_I}\\right)^n} $$\nNext, we derive the expression for the ultrasensitivity response, $R(P) \\equiv \\left|\\frac{d \\ln J}{d \\ln P}\\right|$. First, we take the natural logarithm of $J(P)$:\n$$ \\ln J = \\ln \\left( \\frac{J_0}{1 + (P/K_I)^n} \\right) = \\ln J_0 - \\ln\\left(1 + \\left(\\frac{P}{K_I}\\right)^n\\right) $$\nTo find the derivative with respect to $\\ln P$, we use the chain rule $\\frac{d}{d \\ln P} = P \\frac{d}{dP}$:\n$$ \\frac{d \\ln J}{d \\ln P} = P \\frac{d}{dP} \\left[ \\ln J_0 - \\ln\\left(1 + \\left(\\frac{P}{K_I}\\right)^n\\right) \\right] $$\n$$ \\frac{d \\ln J}{d \\ln P} = -P \\left[ \\frac{1}{1 + (P/K_I)^n} \\cdot \\frac{d}{dP}\\left(\\left(\\frac{P}{K_I}\\right)^n\\right) \\right] $$\n$$ \\frac{d \\ln J}{d \\ln P} = -P \\left[ \\frac{1}{1 + (P/K_I)^n} \\cdot \\frac{n P^{n-1}}{K_I^n} \\right] = - \\frac{n P^n / K_I^n}{1 + (P/K_I)^n} $$\nApplying the absolute value from the definition of $R(P)$:\n$$ R(P) = \\left| - \\frac{n (P/K_I)^n}{1 + (P/K_I)^n} \\right| = \\frac{n (P/K_I)^n}{1 + (P/K_I)^n} $$\nThis completes the first task.\n\nFor the second task, we evaluate $R(P)$ at the specific point $P = K_I$:\n$$ R(K_I) = \\frac{n (K_I/K_I)^n}{1 + (K_I/K_I)^n} = \\frac{n \\cdot 1^n}{1 + 1^n} = \\frac{n}{2} $$\nThe response coefficient $R(P)$ quantifies the local log-log gain, or the fractional change in output $J$ for a given fractional change in input $P$. The result $R(K_I) = n/2$ demonstrates that at the half-inhibition point, the sensitivity of the system is directly proportional to the Hill coefficient $n$. A larger $n$, which corresponds to stronger positive cooperativity in inhibitor binding, results in a higher sensitivity. This is the definition of ultrasensitivity: a small relative change in the inhibitor concentration around $K_I$ can elicit a much larger relative change in the metabolic flux. For $n  2$, the response is ultrasensitive since $R(K_I)  1$.\n\nFinally, we address the third task. The baseline condition is at an end-product concentration of $P_0 = K_I$. The corresponding flux, $J_{baseline}$, is:\n$$ J_{baseline} = J(K_I) = J_0 \\frac{1}{1 + (K_I/K_I)^n} = \\frac{J_0}{2} $$\nA perturbation doubles the inhibitor concentration to $P_{new} = 2 P_0 = 2 K_I$. The new flux, $J_{new}$, is:\n$$ J_{new} = J(2 K_I) = J_0 \\frac{1}{1 + (2K_I/K_I)^n} = J_0 \\frac{1}{1 + 2^n} $$\nThe problem states that this perturbation causes the flux to decrease by a factor of $5$, which means $J_{new} = \\frac{1}{5} J_{baseline}$. We set up the equation:\n$$ J_0 \\frac{1}{1 + 2^n} = \\frac{1}{5} \\left( \\frac{J_0}{2} \\right) $$\nThe $J_0$ terms cancel:\n$$ \\frac{1}{1 + 2^n} = \\frac{1}{10} $$\nSolving for $n$:\n$$ 1 + 2^n = 10 $$\n$$ 2^n = 9 $$\nTo find $n$, we take the natural logarithm of both sides:\n$$ \\ln(2^n) = \\ln(9) $$\n$$ n \\ln(2) = \\ln(3^2) $$\n$$ n \\ln(2) = 2 \\ln(3) $$\nIsolating $n$ gives the final analytical expression:\n$$ n = \\frac{2 \\ln(3)}{\\ln(2)} $$", "answer": "$$ \\boxed{\\frac{2 \\ln(3)}{\\ln(2)}} $$", "id": "2774288"}]}